HomeInsightsEPS

Beryl Drugs Ltd EPS

Beryl Drugs Ltd EPS

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

0.7 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 24, 2024

Image

Beryl Drugs Ltd

NSE: BERYLDRUGS

EPS

₹ 0.67

Last updated on: Nov 22, 2024

Key Highlights

  • The Earning per Share of Beryl Drugs Ltd is ₹ 0.67 as of 22 Nov 24 .
  • The earning per share of Beryl Drugs Ltd changed from ₹ 0.43 to ₹ 0.01 over 10 quarters. This represents a CAGR of -77.79% .

Historical Earning per Share of Beryl Drugs Ltd

No data available

* All values are in

Company Fundamentals for Beryl Drugs Ltd

Market Cap

16 Cr

EPS

0.7

P/E Ratio (TTM) *

48.9

P/B Ratio (TTM) *

1.8

Day’s High *

34.2

Day’s Low

32.35

DTE *

0.5

ROE *

3.6

52 Week High

46.0

52 Week Low

19.51

ROCE *

8.2

Market Price of Beryl Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Beryl Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202432.75
21 Nov 202432.3
19 Nov 202432.75
18 Nov 202433
14 Nov 202433.44
13 Nov 202435.15
12 Nov 202437.05
11 Nov 202438.04
08 Nov 202439.76
07 Nov 202438.06

BlinkX Score for Beryl Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Beryl Drugs Ltd

Market Value

17

Asset Value

11

0.6 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Beryl Drugs Ltd016
Sun Pharmaceuticals Industries Ltd464,31,352
Divis Laboratories Ltd691,59,265
Cipla Ltd571,20,033
Torrent Pharmaceuticals Ltd511,07,301
Mankind Pharma Ltd521,02,231

Historical Market Cap of Beryl Drugs Ltd

No data available

* All values are in crore

Historical Revenue of Beryl Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Beryl Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Beryl Drugs Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Beryl Drugs Ltd News Hub

News

Beryl Drugs to discuss results

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 13 November 20...

Read more

06 Nov 202418:13

News

Beryl Drugs to hold AGM

Beryl Drugs announced that the Annual General Meeting (AGM) of the company will be held on...

Read more

11 Sep 202410:44

News

Beryl Drugs to convene AGM

Beryl Drugs announced that the Annual General Meeting (AGM) of the company will be held on...

Read more

11 Sep 202410:20

News

Beryl Drugs to conduct board meeting

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 3 September 20...

Read more

27 Aug 202411:03

News

Beryl Drugs schedules board meeting

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 9 August 2024....

Read more

31 Jul 202414:01

News

Beryl Drugs to conduct board meeting

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 30 May 2024 Po...

Read more

27 May 202411:45

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Beryl Drugs Ltd

What is the EPS of Beryl Drugs Ltd stock?

The Earnings Per Share (EPS) of Beryl Drugs Ltd is 0.67. An EPS is the amount of net income attributed to each share of a common stock.

How is Beryl Drugs Ltd EPS calculated?

The EPS of Beryl Drugs Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Beryl Drugs Ltd report its EPS?

Beryl Drugs Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Beryl Drugs Ltd EPS?

Factors that influence the EPS of Beryl Drugs Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Beryl Drugs Ltd EPS growth indicate future performance?

Yes, consistent growth in Beryl Drugs Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*